Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/7749

TDMS Study 05210-04 Pathology Tables

NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41

                                                           CORE STUDY




       Facility:  I. I. T. Research Institute

       Chemical CAS #:  100-41-4

       Lock Date:  10/02/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 5            6            1            4                                     
    Natural Death                                      9            6            8            9                                     
    Accidently Killed                                  1                         1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                34           38           40           37                                     
    Natural Death                                      1                                                                            
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (44)         (44)         (44)         (46)                                   
      Infiltration Cellular                            1 (2%)                                                                       
   Intestine Small, Duodenum                          (45)         (48)         (47)         (46)                                   
      Ulcer                                                                                   1 (2%)                                
   Intestine Small, Jejunum                           (46)         (46)         (46)         (45)                                   
      Peyer's Patch, Hyperplasia                                                              1 (2%)                                
   Intestine Small, Ileum                             (47)         (47)         (47)         (46)                                   
      Peyer's Patch, Hyperplasia                                    1 (2%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Basophilic Focus                                 3 (6%)                    4 (8%)       3 (6%)                                
      Clear Cell Focus                                 1 (2%)                    1 (2%)                                             
      Eosinophilic Focus                               5 (10%)      7 (14%)      6 (12%)     22 (44%)                               
      Hemorrhage                                                                 1 (2%)       1 (2%)                                
      Hepatodiaphragmatic Nodule                                                 2 (4%)                                             
      Infiltration Cellular                            3 (6%)                                                                       
      Inflammation                                     1 (2%)       3 (6%)       1 (2%)       1 (2%)                                
      Mineralization                                                                          1 (2%)                                
      Mixed Cell Focus                                                           1 (2%)       1 (2%)                                
      Necrosis                                         1 (2%)       4 (8%)       3 (6%)       4 (8%)                                
      Pigmentation, Hemosiderin                        1 (2%)       1 (2%)                                                          
      Bile Duct, Cyst                                                                         1 (2%)                                
      Hepatocyte, Hypertrophy                                                                 1 (2%)                                
      Hepatocyte, Necrosis                                          1 (2%)                                                          
      Hepatocyte, Syncytial Alteration                                           1 (2%)                                             
      Hepatocyte, Vacuolization Cytoplasmic            2 (4%)                    2 (4%)       1 (2%)                                
      Serosa, Inflammation                                                                    1 (2%)                                
   Mesentery                                          (2)                                                                           
      Fat, Necrosis                                    2 (100%)                                                                     
   Pancreas                                           (50)         (50)         (50)         (49)                                   
      Angiectasis                                                   1 (2%)                                                          
      Atrophy                                                       2 (4%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Cyst                                                          1 (2%)                                                          
      Degeneration                                                  1 (2%)                                                          
      Fibrosis                                                      1 (2%)                                                          
      Infiltration Cellular                            7 (14%)     12 (24%)     12 (24%)     10 (20%)                               
      Necrosis                                                      1 (2%)                                                          
      Acinus, Hyperplasia                              1 (2%)                                                                       
      Duct, Cyst                                                                              1 (2%)                                
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Infiltration Cellular                           30 (60%)     32 (64%)     33 (66%)     30 (60%)                               
   Stomach, Forestomach                               (50)         (49)         (48)         (50)                                   
      Hyperplasia                                                                             2 (4%)                                
      Ulcer                                                                      1 (2%)                                             
      Epithelium, Cyst                                                                        2 (4%)                                
      Epithelium, Hyperplasia                                       2 (4%)                    1 (2%)                                
   Stomach, Glandular                                 (50)         (49)         (48)         (50)                                   
      Infiltration Cellular                            1 (2%)                                                                       
      Glands, Cyst                                     1 (2%)                                                                       
      Glands, Hyperplasia                                                                     1 (2%)                                
      Serosa, Infiltration Cellular                                                           1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (49)         (50)         (50)                                   
      Cardiomyopathy                                  10 (20%)     23 (47%)     23 (46%)     15 (30%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (47)         (50)         (50)         (49)                                   
      Accessory Adrenal Cortical Nodule                2 (4%)       1 (2%)                                                          
      Degeneration                                    12 (26%)      4 (8%)       4 (8%)       5 (10%)                               
      Hemorrhage                                       2 (4%)       1 (2%)       2 (4%)       3 (6%)                                
      Hyperplasia                                      3 (6%)       5 (10%)      3 (6%)       3 (6%)                                
      Infiltration Cellular                                         2 (4%)                                                          
      Inflammation                                                  3 (6%)                                                          
      Necrosis                                         1 (2%)                                                                       
      Vacuolization Cytoplasmic                        1 (2%)                                                                       
      Capsule, Hyperplasia                            46 (98%)     49 (98%)     48 (96%)     46 (94%)                               
   Adrenal Medulla                                    (47)         (50)         (50)         (49)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia                                      2 (4%)       3 (6%)                    1 (2%)                                
   Islets, Pancreatic                                 (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                   2 (4%)       2 (4%)                                             
      Infiltration Cellular                            1 (2%)                    2 (4%)                                             
   Parathyroid Gland                                  (26)         (24)         (34)         (27)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Infiltration Cellular                                         1 (4%)                                                          
   Pituitary Gland                                    (48)         (49)         (47)         (49)                                   
      Pars Distalis, Angiectasis                                                 4 (9%)       2 (4%)                                
      Pars Distalis, Cyst                                           1 (2%)                                                          
      Pars Distalis, Hemorrhage                        3 (6%)                    1 (2%)       1 (2%)                                
      Pars Distalis, Hyperplasia                      10 (21%)     12 (24%)     23 (49%)     22 (45%)                               
      Pars Distalis, Necrosis                                                                 1 (2%)                                
      Pars Intermedia, Hyperplasia                     2 (4%)       1 (2%)                    1 (2%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Infiltration Cellular                                                      1 (2%)                                             
      Follicle, Degeneration                           1 (2%)                                                                       
      Follicular Cell, Hyperplasia                    18 (36%)     23 (46%)     25 (50%)     35 (70%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (1)          (6)          (4)          (1)                                    
      Fat, Necrosis                                                 4 (67%)      3 (75%)      1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (41)         (47)         (48)         (48)                                   
      Atrophy                                                                    1 (2%)                                             
      Degeneration                                                                            1 (2%)                                
   Ovary                                              (49)         (50)         (49)         (49)                                   
      Angiectasis                                      2 (4%)       1 (2%)                                                          
      Atrophy                                                       1 (2%)       1 (2%)                                             
      Cyst                                             8 (16%)      8 (16%)     10 (20%)     10 (20%)                               
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Infiltration Cellular                                                      2 (4%)                                             
      Mineralization                                                                          1 (2%)                                
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                1 (2%)                                             
      Degeneration                                     2 (4%)       1 (2%)                    1 (2%)                                
      Hemorrhage                                                                 1 (2%)       1 (2%)                                
      Infiltration Cellular                                                                   1 (2%)                                
      Inflammation                                     3 (6%)                                 1 (2%)                                
      Thrombosis                                                                 1 (2%)                                             
      Endometrium, Hyperplasia                        44 (88%)     46 (92%)     47 (94%)     46 (92%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (48)         (50)         (50)         (50)                                   
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Infiltration Cellular, Histiocyte                                                       1 (2%)                                
      Inflammation                                     1 (2%)                                                                       
      Myelofibrosis                                                                           2 (4%)                                
      Pigmentation, Hemosiderin                        3 (6%)       1 (2%)       1 (2%)       1 (2%)                                
      Myeloid Cell, Hyperplasia                        1 (2%)                                 1 (2%)                                
   Lymph Node                                         (3)          (7)          (2)          (5)                                    
      Iliac, Hyperplasia                                            1 (14%)                                                         
      Inguinal, Hyperplasia                                                                   1 (20%)                               
      Inguinal, Pigmentation, Hemosiderin              1 (33%)                                                                      
      Lumbar, Hyperplasia                              1 (33%)      2 (29%)                                                         
      Pancreatic, Hyperplasia                                                                 1 (20%)                               
      Renal, Hyperplasia                               1 (33%)                                                                      
      Renal, Necrosis                                               1 (14%)                                                         
   Lymph Node, Bronchial                              (32)         (40)         (29)         (38)                                   
      Hyperplasia                                                   2 (5%)       1 (3%)       2 (5%)                                
   Lymph Node, Mandibular                             (47)         (48)         (47)         (44)                                   
      Hyperplasia                                      1 (2%)       2 (4%)                    2 (5%)                                
   Lymph Node, Mesenteric                             (48)         (48)         (46)         (44)                                   
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hyperplasia                                      4 (8%)       3 (6%)       3 (7%)       2 (5%)                                
      Inflammation                                                  2 (4%)                                                          
      Inflammation, Granulomatous                      1 (2%)       1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
   Lymph Node, Mediastinal                            (34)         (42)         (41)         (31)                                   
      Hyperplasia                                      3 (9%)       4 (10%)                   2 (6%)                                
      Hyperplasia, Histiocytic                         1 (3%)                                                                       
   Spleen                                             (50)         (50)         (50)         (49)                                   
      Hematopoietic Cell Proliferation                 4 (8%)       7 (14%)      2 (4%)       1 (2%)                                
      Hyperplasia                                      1 (2%)                                                                       
      Necrosis                                                      1 (2%)                                                          
      Pigmentation, Hemosiderin                        4 (8%)       1 (2%)       1 (2%)       4 (8%)                                
      Lymphoid Follicle, Hyperplasia                   9 (18%)      5 (10%)      1 (2%)       3 (6%)                                
   Thymus                                             (42)         (44)         (45)         (46)                                   
      Atrophy                                          5 (12%)      5 (11%)      5 (11%)      6 (13%)                               
      Thymocyte, Hyperplasia                           1 (2%)       2 (5%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (49)         (50)         (48)         (49)                                   
      Galactocele                                                   1 (2%)       1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
   Skin                                               (50)         (50)         (49)         (50)                                   
      Fibrosis                                                                   1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Inflammation                                     1 (2%)                    2 (4%)                                             
      Necrosis                                         1 (2%)                                                                       
      Ulcer                                            1 (2%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (50)         (50)         (50)                                   
      Arthrosis                                                                  1 (2%)                                             
      Fracture                                                      2 (4%)                                                          
      Periosteum, Femur, Inflammation                  1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       2 (4%)                                                                       
      Mineralization                                  19 (38%)     17 (34%)     26 (52%)     25 (50%)                               
      Cerebellum, Atrophy                              1 (2%)                                                                       
      Cerebrum, Atrophy                                2 (4%)       1 (2%)       2 (4%)                                             
      Cerebrum, Gliosis                                                                       1 (2%)                                
      Cerebrum, Hemorrhage                                                                    1 (2%)                                
      Medulla, Atrophy                                 1 (2%)                                                                       
      Medulla, Hemorrhage                              1 (2%)                                                                       
      Meninges, Infiltration Cellular                               2 (4%)       1 (2%)                                             
   Spinal Cord                                        (1)                                                                           
      Hemorrhage                                       1 (100%)                                                                     
      Myelin, Degeneration                             1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (49)         (49)         (47)         (48)                                   
      Degeneration                                                               1 (2%)                                             
      Infiltration Cellular                            1 (2%)                    1 (2%)       1 (2%)                                
      Glands, Degeneration                                          2 (4%)       2 (4%)       2 (4%)                                
      Glands, Inflammation                                                       1 (2%)                                             
   Lung                                               (50)         (50)         (49)         (50)                                   
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Infiltration Cellular, Histiocyte                1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                              1 (2%)       3 (6%)       1 (2%)                                
      Alveolar Epithelium, Metaplasia                                                         1 (2%)                                
      Vein, Thrombosis                                 1 (2%)                                                                       
   Nose                                               (49)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation                                     3 (6%)       2 (4%)       3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Nasolacrimal Duct, Inflammation                  1 (2%)                                                                       
      Respiratory Epithelium, Metaplasia, Squamous     2 (4%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Casts Protein                                    1 (2%)                                 1 (2%)                                
      Infiltration Cellular                                         1 (2%)                                                          
      Mineralization                                                                          1 (2%)                                
      Nephropathy                                     13 (26%)      7 (14%)      9 (18%)     21 (42%)                               
      Cortex, Cyst                                                               1 (2%)       1 (2%)                                
      Cortex, Metaplasia, Osseous                                   1 (2%)                                                          
   Urinary Bladder                                    (47)         (48)         (47)         (49)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Infiltration Cellular                            4 (9%)       4 (8%)       4 (9%)       5 (10%)                               
      Inflammation                                     1 (2%)                                                                       
      Ulcer                                            1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 6            2            5            6                                     
    Natural Death                                     15           12           13           13                                     
    Accidently Killed                                  1                                      1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                28           36           31           30                                     
    Natural Death                                                                1                                                  
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (33)         (39)         (37)         (38)                                   
      Epithelium, Hyperplasia                                                    1 (3%)                                             
   Intestine Small, Duodenum                          (45)         (48)         (43)         (45)                                   
      Parasite Metazoan                                                          1 (2%)                                             
      Epithelium, Hyperplasia                                                    1 (2%)       1 (2%)                                
   Intestine Small, Jejunum                           (44)         (46)         (44)         (43)                                   
      Cyst                                                          1 (2%)                                                          
      Epithelium, Dysplasia                                         1 (2%)                                                          
      Peyer's Patch, Hyperplasia                       1 (2%)       1 (2%)                                                          
   Intestine Small, Ileum                             (42)         (46)         (44)         (41)                                   
      Peyer's Patch, Hyperplasia                       1 (2%)                                                                       
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Basophilic Focus                                 3 (6%)       3 (6%)       5 (10%)      4 (8%)                                
      Clear Cell Focus                                 5 (10%)      4 (8%)       7 (14%)      3 (6%)                                
      Cyst                                             1 (2%)       1 (2%)                                                          
      Eosinophilic Focus                               6 (12%)      8 (16%)      8 (16%)     12 (24%)                               
      Eosinophilic Focus, Multiple                     1 (2%)                                                                       
      Fibrosis                                                      1 (2%)                    1 (2%)                                
      Hemorrhage                                                                              2 (4%)                                
      Hepatodiaphragmatic Nodule                                                 1 (2%)                                             
      Inflammation, Chronic                                         2 (4%)                                                          
      Mineralization                                                             1 (2%)                                             
      Mixed Cell Focus                                 3 (6%)       2 (4%)                    1 (2%)                                
      Necrosis                                         7 (14%)      8 (16%)     10 (20%)     10 (20%)                               
      Thrombosis                                                                              1 (2%)                                
      Hepatocyte, Hyperplasia                                                                 1 (2%)                                
      Hepatocyte, Hypertrophy                          1 (2%)                                17 (34%)                               
      Hepatocyte, Necrosis                             1 (2%)       1 (2%)       3 (6%)      10 (20%)                               
      Hepatocyte, Syncytial Alteration                              5 (10%)      8 (16%)     23 (46%)                               
      Hepatocyte, Vacuolization Cytoplasmic            4 (8%)       2 (4%)       4 (8%)       3 (6%)                                
      Vein, Thrombosis                                 1 (2%)                    2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Pancreas                                           (49)         (50)         (48)         (48)                                   
      Inflammation                                     1 (2%)                                                                       
      Acinus, Hyperplasia                                                                     1 (2%)                                
      Duct, Cyst                                       1 (2%)       1 (2%)                                                          
      Duct, Degeneration                                                                      1 (2%)                                
      Duct, Fibrosis                                   1 (2%)                                                                       
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Infiltration Cellular                           21 (42%)     26 (52%)     17 (34%)     20 (40%)                               
   Stomach, Forestomach                               (48)         (50)         (50)         (47)                                   
      Cyst                                                                                    1 (2%)                                
      Ulcer                                            1 (2%)                                                                       
      Epithelium, Hyperplasia                                                                 1 (2%)                                
      Serosa, Inflammation                                                                    1 (2%)                                
   Stomach, Glandular                                 (48)         (50)         (50)         (47)                                   
      Infiltration Cellular                            1 (2%)                                                                       
      Inflammation                                                               1 (2%)                                             
      Metaplasia                                       1 (2%)                                                                       
      Mineralization                                                             2 (4%)                                             
   Tongue                                                                                    (1)                                    
      Inflammation, Granulomatous                                                             1 (100%)                              
   Tooth                                                                        (1)          (1)                                    
      Developmental Malformation                                                 1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  18 (36%)     36 (72%)     29 (58%)     25 (50%)                               
      Inflammation                                     2 (4%)                                                                       
      Myocardium, Mineralization                       1 (2%)                                                                       
      Pericardium, Hyperplasia                         1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (47)         (47)         (48)         (48)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)                                                                       
      Degeneration                                     1 (2%)       2 (4%)       1 (2%)                                             
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Hyperplasia                                     13 (28%)      8 (17%)      9 (19%)      4 (8%)                                
      Vacuolization Cytoplasmic                        1 (2%)                                                                       
      Capsule, Hyperplasia                            19 (40%)     22 (47%)     20 (42%)     17 (35%)                               
   Adrenal Medulla                                    (47)         (46)         (48)         (48)                                   
      Degeneration                                                               1 (2%)                                             
      Hyperplasia                                                                2 (4%)                                             
      Mineralization                                                             1 (2%)                                             
   Islets, Pancreatic                                 (49)         (50)         (48)         (48)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Degeneration                                                               1 (2%)                                             
      Hyperplasia                                      5 (10%)      5 (10%)      8 (17%)      1 (2%)                                
   Pituitary Gland                                    (44)         (45)         (45)         (47)                                   
      Pars Distalis, Cyst                                           1 (2%)       2 (4%)       1 (2%)                                
      Pars Distalis, Hyperplasia                       1 (2%)       1 (2%)       1 (2%)                                             
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Follicle, Cyst                                                             1 (2%)                                             
      Follicular Cell, Hyperplasia                    21 (42%)     21 (42%)     29 (58%)     32 (64%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (2)          (3)          (1)          (2)                                    
      Cyst                                                          1 (33%)                                                         
      Fat, Necrosis                                                 2 (67%)                   1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (50)         (50)         (50)                                   
      Atypia Cellular                                  1 (2%)       1 (2%)                                                          
      Cyst                                             1 (2%)                                                                       
      Degeneration                                                                            2 (4%)                                
      Fibrosis                                                      1 (2%)                                                          
      Granuloma Sperm                                  2 (4%)       1 (2%)       1 (2%)                                             
      Infiltration Cellular                                         1 (2%)                                                          
      Inflammation                                     1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
      Bilateral, Fibrosis                                                        1 (2%)                                             
   Penis                                              (1)          (2)                                                              
      Concretion                                                    1 (50%)                                                         
      Inflammation                                     1 (100%)     1 (50%)                                                         
   Preputial Gland                                    (48)         (49)         (48)         (49)                                   
      Cyst                                                                       1 (2%)                                             
      Degeneration                                     3 (6%)       3 (6%)       9 (19%)      6 (12%)                               
      Degeneration, Cystic                                          1 (2%)                                                          
      Fibrosis                                                                   1 (2%)                                             
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
      Infiltration Cellular                            1 (2%)       5 (10%)      6 (13%)      4 (8%)                                
      Inflammation                                     6 (13%)     11 (22%)     11 (23%)     13 (27%)                               
      Mineralization                                                1 (2%)                                                          
      Necrosis                                                                   1 (2%)                                             
   Prostate                                           (46)         (49)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                                                       
      Infiltration Cellular                            1 (2%)       2 (4%)       1 (2%)       2 (4%)                                
      Inflammation                                     6 (13%)      5 (10%)      5 (10%)      6 (12%)                               
   Seminal Vesicle                                    (49)         (50)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Atrophy                                          2 (4%)       1 (2%)       3 (6%)       1 (2%)                                
      Degeneration                                    19 (39%)     26 (52%)     16 (32%)     22 (44%)                               
      Inflammation                                     1 (2%)       1 (2%)       2 (4%)                                             
   Testes                                             (49)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                    1 (2%)                                
      Mineralization                                                                          1 (2%)                                
      Germinal Epithelium, Atrophy                                  1 (2%)                                                          
      Germinal Epithelium, Degeneration                                                       1 (2%)                                
      Interstitial Cell, Hyperplasia                                1 (2%)                                                          
      Tunic, Fibrosis                                                            1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hyperplasia                                      1 (2%)                                                                       
      Pigmentation, Hemosiderin                        2 (4%)       2 (4%)                    1 (2%)                                
      Myeloid Cell, Hyperplasia                        2 (4%)       4 (8%)       9 (18%)      4 (8%)                                
   Lymph Node                                         (4)          (7)          (11)         (3)                                    
      Inguinal, Hyperplasia                            1 (25%)      1 (14%)                                                         
      Inguinal, Pigmentation                                        1 (14%)                                                         
      Lumbar, Congestion                                                         1 (9%)                                             
      Lumbar, Hyperplasia                              1 (25%)      4 (57%)      4 (36%)      2 (67%)                               
      Lumbar, Inflammation                                                       2 (18%)                                            
      Lumbar, Pigmentation                                          1 (14%)                   1 (33%)                               
      Renal, Congestion                                                          2 (18%)                                            
      Renal, Hyperplasia                                            3 (43%)      3 (27%)                                            
   Lymph Node, Mandibular                             (43)         (45)         (46)         (44)                                   
      Pigmentation, Hemosiderin                                     1 (2%)                    1 (2%)                                
   Lymph Node, Mesenteric                             (45)         (46)         (47)         (48)                                   
      Atrophy                                                                                 1 (2%)                                
      Congestion                                       1 (2%)       3 (7%)       1 (2%)       2 (4%)                                
      Hematopoietic Cell Proliferation                              3 (7%)                                                          
      Hyperplasia                                      1 (2%)       2 (4%)       3 (6%)                                             
      Inflammation                                                  2 (4%)                    1 (2%)                                
   Lymph Node, Mediastinal                            (24)         (25)         (27)         (25)                                   
      Hyperplasia                                      1 (4%)                                                                       
   Spleen                                             (50)         (50)         (49)         (49)                                   
      Atrophy                                          1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 3 (6%)       4 (8%)       2 (4%)                                             
      Lymphoid Follicle, Atrophy                       2 (4%)                    1 (2%)       1 (2%)                                
      Lymphoid Follicle, Hyperplasia                                             2 (4%)                                             
   Thymus                                             (37)         (37)         (39)         (34)                                   
      Atrophy                                         18 (49%)     11 (30%)     20 (51%)     11 (32%)                               
      Cyst                                             1 (3%)                                                                       
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (3)          (2)          (3)          (3)                                    
      Atrophy                                          1 (33%)      1 (50%)      2 (67%)      1 (33%)                               
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)                                                          
      Infiltration Cellular, Melanocyte                             1 (2%)                                                          
      Inflammation                                     3 (6%)       6 (12%)      4 (8%)       3 (6%)                                
      Necrosis                                         1 (2%)                                                                       
      Ulcer                                            1 (2%)       5 (10%)      2 (4%)       3 (6%)                                
      Hair Follicle, Atrophy                                        1 (2%)                                                          
      Prepuce, Degeneration                                                      1 (2%)                                             
      Prepuce, Hyperplasia, Lymphoid                                             1 (2%)                                             
      Prepuce, Inflammation                                                      2 (4%)                                             
      Prepuce, Ulcer                                                             2 (4%)                                             
      Sebaceous Gland, Cyst                                         1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (49)         (50)         (50)                                   
      Vertebra, Degeneration                           1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Mineralization                                  21 (42%)     18 (36%)     19 (38%)     19 (38%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (48)         (49)         (46)         (49)                                   
      Foreign Body                                                               1 (2%)                                             
      Hemorrhage                                                                              1 (2%)                                
      Infiltration Cellular                            1 (2%)       4 (8%)       4 (9%)                                             
      Glands, Degeneration                                          1 (2%)       3 (7%)       2 (4%)                                
      Glands, Inflammation                                          1 (2%)       2 (4%)                                             
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                                                 1 (2%)                                             
      Hemorrhage                                                                              1 (2%)                                
      Infiltration Cellular, Histiocyte                2 (4%)                    1 (2%)       2 (4%)                                
      Inflammation                                     1 (2%)                                                                       
      Pigmentation, Hemosiderin                                                  1 (2%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 1 (2%)       5 (10%)      2 (4%)       4 (8%)                                
      Alveolar Epithelium, Metaplasia                               1 (2%)       2 (4%)       6 (12%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
   Nose                                               (50)         (50)         (50)         (50)                                   
      Edema                                                                                   1 (2%)                                
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Inflammation                                     7 (14%)      3 (6%)       4 (8%)       1 (2%)                                
      Polyp, Inflammatory                              2 (4%)       1 (2%)       2 (4%)                                             
      Nasolacrimal Duct, Inflammation                  3 (6%)                    1 (2%)       1 (2%)                                
      Respiratory Epithelium, Inflammation                                                    1 (2%)                                
      Respiratory Epithelium, Metaplasia, Squamous                  1 (2%)                                                          
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Glands, Cyst                                                                            1 (2%)                                
      Glands, Hemorrhage                                                                      1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Degeneration                                     1 (2%)                                                                       
      Infarct                                          1 (2%)                                                                       
      Inflammation                                     3 (6%)       5 (10%)      5 (10%)      3 (6%)                                
      Metaplasia, Osseous                                           1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Nephropathy                                     34 (68%)     38 (76%)     40 (80%)     36 (72%)                               
      Pigmentation, Bile                               1 (2%)                                                                       
      Cortex, Cyst                                     1 (2%)       8 (16%)      5 (10%)      4 (8%)                                
      Papilla, Inflammation                            3 (6%)       4 (8%)       3 (6%)       2 (4%)                                
      Papilla, Necrosis                                                          1 (2%)                                             
      Pelvis, Dilatation                               1 (2%)       2 (4%)       1 (2%)       3 (6%)                                
      Renal Tubule, Vacuolization Cytoplasmic                                    1 (2%)                                             
   Ureter                                                                       (2)          (1)                                    
      Degeneration                                                               1 (50%)      1 (100%)                              
      Inflammation                                                               1 (50%)                                            
   Urinary Bladder                                    (48)         (50)         (49)         (49)                                   
      Calculus Micro Observation Only                  1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Infiltration Cellular                                                      1 (2%)       1 (2%)                                
      Inflammation                                     7 (15%)     12 (24%)      6 (12%)      8 (16%)                               
      Ulcer                                                         1 (2%)                                                          
      Muscularis, Inflammation                                                   1 (2%)                                             
      Muscularis, Necrosis                                                       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05210-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ETHYLBENZENE                                       Date: 04/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 08:53:41  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      75 PPM       250          750                                       
                                                                             PPM          PPM                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Serosa, Fibrosis                                                           1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------